ArticleMolecular therapy oncolytics2023

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions.

Norris Lam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.